|
GCN1L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37389999999016E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.54260000000606E-05 |
| Normal-vs-Stage2 |
1.954490E-02 |
| Normal-vs-Stage3 |
4.87560000039799E-07 |
| Normal-vs-Stage4 |
1.25290000041467E-07 |
| Stage1-vs-Stage2 |
3.250000E-01 |
| Stage1-vs-Stage3 |
3.531000E-01 |
| Stage1-vs-Stage4 |
9.049900E-02 |
| Stage2-vs-Stage3 |
1.481190E-01 |
| Stage2-vs-Stage4 |
5.993700E-02 |
| Stage3-vs-Stage4 |
5.083400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68501999999737E-05 |
| Normal-vs-AfricanAmerican |
1.145920E-02 |
| Normal-vs-Asian |
5.85220000000053E-05 |
| Caucasian-vs-AfricanAmerican |
3.699800E-01 |
| Caucasian-vs-Asian |
7.446400E-01 |
| AfricanAmerican-vs-Asian |
3.407200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48980000003185E-06 |
| Normal-vs-Female |
1.51090999999104E-05 |
| Male-vs-Female |
3.785200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31349999999519E-05 |
| Normal-vs-Age(41-60Yrs) |
2.6223000000325E-06 |
| Normal-vs-Age(61-80Yrs) |
5.00830000027541E-07 |
| Normal-vs-Age(81-100Yrs) |
5.924300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.061800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.341000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.298000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.765200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.207800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.750800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.828400E-02 |
| Classical-VS-Follicular |
1.615040E-01 |
| Classical-VS-Other |
6.338300E-02 |
| Classical-VS-Normal |
3.77970000000616E-05 |
| Tall-VS-Follicular |
3.620600E-01 |
| Tall-VS-Other |
4.039800E-01 |
| Tall-VS-Normal |
8.93589999995115E-07 |
| Follicular-VS-Other |
3.695000E-01 |
| Follicular-VS-Normal |
3.59920000000402E-05 |
| Other-VS-Normal |
5.964600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.04699999999391E-05 |
| Normal-vs-N1 |
1.72670000520014E-08 |
| N0-vs-N1 |
2.583600E-02 |
|
|
